VIMRxyn chemically synthesized oral hypericin: VMRX will begin a Phase I trial in September

VimRx Pharmaceuticals Inc. (VMRX), Stamford, Conn. Product: VIMRxyn chemically synthesized oral hypericin Indication: Malignant glioma Status: VMRX will begin a Phase I trial in September in 16 patien...